Pantoprazole Sodium Delayed-Release Tablets — Class II drug recall D-0852-2022
Terminated recall by Torrent Pharma Inc, reported 2022-05-11, distributed nationwide. CGMP deviations: tablets cracking
| Recall number | D-0852-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Torrent Pharma Inc, Levittown, PA, United States |
| Recall initiated | 2022-04-11 |
| Classified | 2022-05-05 |
| Reported by FDA | 2022-05-11 |
| Terminated | 2023-07-25 |
| Distributed | Nationwide (US) |
| Quantity | 24,888 bottles |
| Reason classes | cgmp, packaging |
| NDC | 13668-0096, 13668-0096-90, 13668-0429, 13668-0429-05, 13668-0429-10, 13668-0429-30, 13668-0429-90 |
| Lot numbers | BA34G021, BA34G022 |
| Expiration dates | 2022-09 |
Product
Pantoprazole Sodium Delayed-Release Tablets, USP, 20 mg, Rx Only, 90 tablets per bottle, Manufactured by: Torrent Pharmaceuticals Ltd., Indrad-382 721, India, Manufactured for: Torrent Pharma Inc., Levittown, PA 19057, NDC# 13668-096-90.
Reason for recall
CGMP deviations: tablets cracking
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0852-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.